ABAnne Booth

Anne Booth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anne Booth has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Correction to: Treatment decision‑making in sickle cell disease patients

    by A. Booth, V. Bonham, M. Porteus, K. E. Ormond

  • Treatment decision-making in sickle cell disease patients

    by A. Booth, V. Bonham, M. Porteus, K. E. Ormond

    Sickle cell disease (SCD) is a blood disorder with few treatment options currently available. However, in recent years, there has been much progress toward developing new therapies and curative treatments to help patients with SCD. Stem cell transplant remains the only approved curative treatment for SCD, but new clinical trials are being initiated using gene therapy and gene editing. We surveyed patients with sickle cell disease (N=9) about attitudes toward stem cell transplant, gene therapy to add a new healthy gene, gene editing to up-regulate fetal hemoglobin, or gene editing to correct the point mutation. The participants read a fact sheet that included objective information on each curative treatment. When asked which curative treatment each participant would choose, all four options were selected at least once. The most highly selected treatment was gene correction gene editing (N=4). Participants generally agreed that the four treatment options are beneficial but were more mixed in their thoughts on whether the options are dangerous. Reasons for selecting a particular curative treatment were variable, but the most selected reasons were perception of a cure (N=4) or decreased severity (N=4), and not needing a donor (N=4). We are at the beginning stages of understanding how patients with SCD make decisions about curative treatments. Currently, patients may be interested in any of the four possibilities for curative treatments, with gene correction gene editing as the most popular choice. Reasons for choosing one treatment over another are mixed.


  • Screening for learning disability in an adolescent forensic population

    by Greta Ford, Ruth Andrews, Anne Booth, Jamie Dibdin, Samantha Hardingham, Thomas P. Kelly

    It is recognised in the literature that learning disability (LD) and learning difficulties are represented in greater proportions among adolescent offenders than in the broader adolescent population. However at this time no common method for identifying these difficulties is used within the youth justice system (YJS) in England and Wales. A sample of 71 young people within the YJS in the north-east of England completed the Hayes Ability Screening Index, together with standard measures of cognitive functioning (Wechsler intelligence scale: WISC-IV and WAIS-III) and adaptive behaviour (Vineland Adaptive Behaviour Scales). HASI results were compared to the results of these diagnostic measures to assess the utility of the HASI in identifying those who warrant more detailed assessment for LD. Analysis revealed that in this UK population the HASI did not have adequate specificity to be helpful in identifying which young people should be referred for further assessment by specialist LD services. Future investigations should seek to identify a tool or process which would efficiently identify LD within the YJS in order better to serve the needs of this vulnerable group.


  • Unrecognised 180ˆ torsion of a pregnant uterus

    by T. Poulose, R. Fox, A. Booth

    (2006). Unrecognised 180ˆ torsion of a pregnant uterus. Journal of Obstetrics and Gynaecology: Vol. 26, No. 1, pp. 70-71.